Pharma boss: EU will have to focus on long-term medical research ecosystem
After the coronavirus crisis is over, Europe will need policies that can create a research ecosystem in the long run as well as ensure access to medicines to the patients who need them in a way that is sustainable for health systems today and tomorrow, a top European pharmaceutical official told EURACTIV in an interview.
“We believe that by working together and sitting around the table, post-COVID, Europe can achieve both of these ambitions,” said Nathalie Moll, the director-general of the European Federation of Pharmaceutical Industries and Associations (EFPIA).
She added that EFPIA members are working around the clock to find vaccines, diagnostics and treatments to use in the fight against coronavirus.
To read the full interview, click here.